The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if magnesium can improve blood pressure, cholesterol, and blood sugar control in patients with implantable cardioverter defibrillators (ICDs).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hartford Hospital
• Collaborator: Hartford Hospital(HH) Research Endowment Funds

Criteria

Inclusion Criteria:

• Newly implanted ICD or recent ICD shock (within 6 months)

Exclusion Criteria:

• Inability to swallow

• A non-cardiac disease with a survival prognosis of less than 12 months

• Hypermagnesemia

• Creatinine clearance less than 30mL/min

• Lactic acidosis or systemic acidosis syndrome

• Previous intolerance to magnesium L-lactate